Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg Capsules

Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg combines a statin with two antiplatelet medicines for selected patients with established cardiovascular disease, including some post-coronary-intervention regimens. It addresses raised cholesterol and platelet-driven arterial clot formation.
Take the capsule with food and swallow it whole. Keep the treatment schedule consistent. Do not interrupt the aspirin-clopidogrel component independently, particularly after coronary stenting, because premature withdrawal can permit a serious clot.
Rosuvastatin lowers LDL cholesterol by inhibiting hepatic cholesterol synthesis. Aspirin reduces thromboxane-mediated platelet activation, while clopidogrel blocks the platelet P2Y12 receptor, providing complementary antiplatelet effects.
Easy bruising, nosebleeds, indigestion, abdominal discomfort and muscle aches can occur. Persistent bleeding, black stools, vomiting blood or a sudden neurological deficit needs urgent care.
Dual antiplatelet treatment increases bleeding risk. Previous ulcer bleeding, low platelets, kidney or liver disease and planned surgery are important. NSAIDs and anticoagulants add risk. Omeprazole and esomeprazole can reduce clopidogrel activation.
Targets LDL-related atherosclerotic risk and platelet-mediated clotting when all three components are part of the intended cardiac regimen.
Aspirin and clopidogrel block different platelet activation pathways. Selected situations, such as after some coronary interventions, benefit from this combined effect.
No. That would remove both antiplatelet ingredients and could leave an important treatment gap.
Omeprazole and esomeprazole inhibit an enzyme needed to activate clopidogrel; an appropriate alternative may be needed.
The surgical and cardiac teams need to agree a plan that balances bleeding against clotting risk, especially after a stent.
Minor bruising can occur, but uncontrolled or internal bleeding is different. Stopping without a plan can also be hazardous.
Dual antiplatelet therapy: treatment with two platelet-inhibiting medicines. P2Y12: a platelet receptor blocked by clopidogrel. Stent thrombosis: a clot forming within a coronary stent. Atherosclerotic risk: risk related to arterial plaque disease; AR: Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg كبسولات; FR: Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg gélules; PT: Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg cápsulas; ES: Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg cápsulas; RU: Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg капсулы; ID: Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg kapsul; VI: Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg viên nang; MS: Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg kapsul; TL: Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg kapsula; ZH-SG: Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg 胶囊
International B2B Enquiry
Send a structured B2B enquiry for Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg Capsules under Cardiac Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg Capsules